Elizabeth Holmes, former Theranos CEO, begins 11-year jail sentence for defrauding investors.
Theranos, once valued at $10 billion, exposed as a cautionary tale of startup culture.
Theranos' revolutionary blood testing claims proved inaccurate, leading to downfall
Investigation reveals Theranos' false positives for conditions like cancer and HIV
Wall Street Journal reporter John Carreyrou uncovers Theranos' fraudulent practices
Elizabeth Holmes found guilty of defrauding investors, not patients
Theranos' COO Ramesh Balwani also convicted in the fraud case
Lessons learned: The importance of due diligence in the biotech industry
CLICK HERE FOR MORE CONTENT>>>